Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C097240 |
15-deoxy-delta(12,14)-prostaglandin J2 |
[15-deoxy-delta(12,14)-prostaglandin J2 co-treated with alitretinoin] results in increased expression of PTEN protein | affects cotreatment|increases expression | 16611854
|
C486182 |
2,3-bis(4-hydroxyphenyl)-propionitrile |
2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of PTEN protein | increases expression | 19264808
|
C486182 |
2,3-bis(4-hydroxyphenyl)-propionitrile |
ESR1 protein affects the reaction [2,3-bis(4-hydroxyphenyl)-propionitrile results in increased expression of PTEN protein] | affects reaction|increases expression | 19264808
|
C085911 |
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
[decitabine co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Sirolimus] results in increased expression of PTEN mRNA | affects cotreatment|increases expression | 18622747
|
C486184 |
4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol |
4,4',4''-(4-propyl-((1)H)-pyrazole-1,3,5-triyl) tris-phenol results in increased expression of PTEN protein | increases expression | 19264808
|
C103303 |
alitretinoin |
[15-deoxy-delta(12,14)-prostaglandin J2 co-treated with alitretinoin] results in increased expression of PTEN protein | affects cotreatment|increases expression | 16611854
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of PTEN mRNA | affects expression | 16483693
|
D000643 |
Ammonium Chloride |
Ammonium Chloride results in decreased expression of PTEN protein | decreases expression | 16483693
|
D001554 |
Benzene |
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of PTEN mRNA | affects cotreatment|increases expression | 17905399
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of PTEN mRNA | increases expression | 20504355
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PTEN mRNA | decreases expression | 19150397 20018196
|
C053541 |
bicalutamide |
bicalutamide promotes the reaction [PTEN protein results in decreased expression of KLK3 mRNA] | decreases expression|increases reaction | 16637073
|
C053541 |
bicalutamide |
bicalutamide results in increased activity of PTEN protein | increases activity | 16637073
|
C006780 |
bisphenol A |
bisphenol A affects the expression of PTEN mRNA | affects expression | 20170705
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in increased expression of PTEN mRNA | increases expression | 15336504
|
D002087 |
Butyrates |
Butyrates results in increased expression of PTEN mRNA | increases expression | 16042588
|
C045645 |
cilostazol |
cilostazol results in decreased phosphorylation of PTEN protein | decreases phosphorylation | 15978173
|
D003042 |
Cocaine |
Cocaine affects the expression of PTEN mRNA | affects expression | 15681117
|
C014347 |
decitabine |
[decitabine affects the methylation of PTEN promoter] which affects the expression of PTEN mRNA | affects expression|affects methylation | 18431742
|
C014347 |
decitabine |
[decitabine co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Sirolimus] results in increased expression of PTEN mRNA | affects cotreatment|increases expression | 18622747
|
C014347 |
decitabine |
decitabine results in decreased methylation of PTEN gene | decreases methylation | 21170675
|
C014347 |
decitabine |
decitabine results in increased expression of PTEN mRNA | increases expression | 21170675
|
D002945 |
Cisplatin |
Cisplatin results in increased activity of PTEN protein | increases activity | 11707646
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in decreased expression of PTEN mRNA | decreases expression | 16804899
|
D004317 |
Doxorubicin |
[Doxorubicin co-treated with trichostatin A] results in increased expression of PTEN mRNA | affects cotreatment|increases expression | 17330857
|
D004317 |
Doxorubicin |
Doxorubicin results in increased activity of PTEN protein | increases activity | 11707646
|
D004317 |
Doxorubicin |
PTEN protein affects the susceptibility to [Doxorubicin co-treated with trichostatin A] | affects cotreatment|affects response to substance | 17330857
|
D004317 |
Doxorubicin |
PTEN protein inhibits the reaction [Doxorubicin results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 17935137
|
D004317 |
Doxorubicin |
PTEN protein promotes the reaction [Doxorubicin results in decreased expression of AKT1 protein modified form] | decreases expression|increases reaction | 16438844
|
D004317 |
Doxorubicin |
PTEN protein promotes the reaction [Doxorubicin results in decreased expression of BAD protein modified form] | decreases expression|increases reaction | 16438844
|
D004317 |
Doxorubicin |
PTEN protein promotes the reaction [Doxorubicin results in decreased phosphorylation of AKT1 protein] | decreases phosphorylation|increases reaction | 17359293
|
D004317 |
Doxorubicin |
PTEN protein promotes the reaction [Doxorubicin results in decreased phosphorylation of BAD protein] | decreases phosphorylation|increases reaction | 17359293
|
D004317 |
Doxorubicin |
PTEN protein results in increased susceptibility to Doxorubicin | increases response to substance | 17359293 17935137 16438844
|
D004317 |
Doxorubicin |
PTEN results in increased susceptibility to Doxorubicin | increases response to substance | 15548710
|
D004317 |
Doxorubicin |
wortmannin inhibits the reaction [PTEN protein results in increased susceptibility to Doxorubicin] | decreases reaction|increases response to substance | 17935137
|
D004958 |
Estradiol |
ESR1 protein affects the reaction [Estradiol results in increased expression of PTEN mRNA] | affects reaction|increases expression | 19264808
|
D004958 |
Estradiol |
ESR1 protein affects the reaction [Estradiol results in increased expression of PTEN protein] | affects reaction|increases expression | 19264808
|
D004958 |
Estradiol |
ESR1 protein alternative form inhibits the reaction [Estradiol results in increased expression of PTEN mRNA] | decreases reaction|increases expression | 20302909
|
D004958 |
Estradiol |
ESR1 protein alternative form inhibits the reaction [Estradiol results in increased expression of PTEN protein] | decreases reaction|increases expression | 20302909
|
D004958 |
Estradiol |
Estradiol results in increased expression of PTEN mRNA | increases expression | 20302909
|
D004958 |
Estradiol |
Estradiol results in increased expression of PTEN protein | increases expression | 20302909 19264808
|
D004958 |
Estradiol |
PTEN protein affects the reaction [Estradiol promotes the reaction [AKT1 protein modified form binds to IRS1 protein]] | affects binding|affects reaction|increases reaction | 19435893
|
D004958 |
Estradiol |
[Estradiol co-treated with Norepinephrine] results in decreased expression of PTEN mRNA | affects cotreatment|decreases expression | 16954335
|
D004958 |
Estradiol |
Estradiol results in decreased expression of PTEN mRNA | decreases expression | 16954335
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of PTEN mRNA | affects expression | 20170705
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PTEN mRNA | affects cotreatment|increases expression | 17942748
|
D005038 |
Ethylnitrosourea |
Ethylnitrosourea results in increased mutagenesis of PTEN gene | increases mutagenesis | 15755804 16724327
|
D005047 |
Etoposide |
PTEN protein inhibits the reaction [Etoposide results in increased phosphorylation of and results in increased activity of AKT1 protein] | decreases reaction|increases activity|increases phosphorylation | 17935137
|
D005047 |
Etoposide |
PTEN protein results in increased susceptibility to Etoposide | increases response to substance | 17935137
|
D005047 |
Etoposide |
wortmannin inhibits the reaction [PTEN protein results in increased susceptibility to Etoposide] | decreases reaction|increases response to substance | 17935137
|
D005472 |
Fluorouracil |
Fluorouracil results in decreased expression of PTEN mRNA | decreases expression | 17039268
|
C070081 |
fulvestrant |
PTEN protein results in increased susceptibility to fulvestrant | increases response to substance | 19435893
|
C056507 |
gemcitabine |
gemcitabine affects the expression of PTEN mRNA | affects expression | 17039268
|
D019833 |
Genistein |
Genistein affects the expression of PTEN mRNA | affects expression | 18431742
|
D019833 |
Genistein |
Genistein affects the expression of PTEN protein | affects expression | 18431742
|
D019833 |
Genistein |
Genistein inhibits the reaction [HIST3H3 protein modified form binds to PTEN promoter] | affects binding|decreases reaction | 18431742
|
D019833 |
Genistein |
Genistein results in increased expression of PTEN mRNA | increases expression | 15829497
|
D019833 |
Genistein |
Genistein results in increased expression of PTEN protein | increases expression | 15829497
|
D019833 |
Genistein |
[[Genistein results in increased expression of PTEN protein] which results in decreased activity of AKT1 protein] which results in increased activity of FOXO3 protein | decreases activity|increases activity|increases expression | 18431742
|
D019833 |
Genistein |
[[Genistein results in increased expression of PTEN protein] which results in decreased activity of AKT1 protein] which results in increased expression of TP53 protein | decreases activity|increases expression | 18431742
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in increased oxidation of and results in decreased activity of PTEN protein | decreases activity|increases oxidation | 11916965
|
C030957 |
methylmercury II |
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of PTEN mRNA | affects cotreatment|increases expression | 17905399
|
D008770 |
Methylnitrosourea |
Methylnitrosourea results in decreased expression of PTEN mRNA | decreases expression | 16616109
|
C008493 |
methylselenic acid |
methylselenic acid results in increased expression of PTEN mRNA | increases expression | 12517777
|
D015741 |
Metribolone |
PTEN protein results in decreased susceptibility to Metribolone | decreases response to substance | 16637073
|
C029938 |
nickel sulfate |
nickel sulfate results in increased expression of PTEN mRNA | increases expression | 16780908
|
D009638 |
Norepinephrine |
[Estradiol co-treated with Norepinephrine] results in decreased expression of PTEN mRNA | affects cotreatment|decreases expression | 16954335
|
D009638 |
Norepinephrine |
Norepinephrine inhibits the reaction [Testosterone results in decreased expression of PTEN mRNA] | decreases expression|decreases reaction | 16954335
|
D009638 |
Norepinephrine |
[Progesterone co-treated with Norepinephrine] results in increased expression of PTEN mRNA | affects cotreatment|increases expression | 16954335
|
D017239 |
Paclitaxel |
Paclitaxel results in increased activity of PTEN protein | increases activity | 11707646
|
D017239 |
Paclitaxel |
PTEN results in increased susceptibility to Paclitaxel | increases response to substance | 15548710
|
D010713 |
Phosphatidylcholines |
PTEN protein binds to Phosphatidylcholines | affects binding | 15313215
|
D010713 |
Phosphatidylcholines |
[TXN protein binds to PTEN protein] inhibits the reaction [PTEN protein binds to Phosphatidylcholines] | affects binding|decreases reaction | 15313215
|
C483858 |
phosphatidylethanolamine |
PTEN protein binds to phosphatidylethanolamine | affects binding | 15313215
|
C483858 |
phosphatidylethanolamine |
[TXN protein binds to PTEN protein] inhibits the reaction [PTEN protein binds to phosphatidylethanolamine] | affects binding|decreases reaction | 15313215
|
C060974 |
phosphatidylinositol 3,4,5-triphosphate |
PTEN protein results in decreased phosphorylation of and results in increased activity of phosphatidylinositol 3,4,5-triphosphate | decreases phosphorylation|increases activity | 12888921
|
C060974 |
phosphatidylinositol 3,4,5-triphosphate |
PTEN protein results in increased hydrolysis of and results in decreased activity of phosphatidylinositol 3,4,5-triphosphate | decreases activity|increases hydrolysis | 15313215
|
D010718 |
Phosphatidylserines |
PTEN protein binds to Phosphatidylserines | affects binding | 15313215
|
D010718 |
Phosphatidylserines |
[TXN protein binds to PTEN protein] inhibits the reaction [PTEN protein binds to Phosphatidylserines] | affects binding|decreases reaction | 15313215
|
C035988 |
procymidone |
procymidone results in increased expression of PTEN mRNA | increases expression | 15686871
|
D011374 |
Progesterone |
Progesterone affects the expression of PTEN mRNA | affects expression | 17251523
|
D011374 |
Progesterone |
[Progesterone co-treated with Norepinephrine] results in increased expression of PTEN mRNA | affects cotreatment|increases expression | 16954335
|
C031280 |
pyrazole |
pyrazole results in decreased expression of PTEN mRNA | decreases expression | 17945193
|
D011794 |
Quercetin |
Quercetin results in increased expression of PTEN mRNA | increases expression | 14715546 15829497
|
D011794 |
Quercetin |
Quercetin results in increased expression of PTEN protein | increases expression | 15829497
|
D011794 |
Quercetin |
Quercetin results in increased expression of PTEN mRNA | increases expression | 18095365
|
C059514 |
resveratrol |
resveratrol results in increased expression of PTEN mRNA | increases expression | 15829497
|
C059514 |
resveratrol |
resveratrol results in increased expression of PTEN protein | increases expression | 15829497
|
D020123 |
Sirolimus |
[decitabine co-treated with 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Sirolimus] results in increased expression of PTEN mRNA | affects cotreatment|increases expression | 18622747
|
C009277 |
sodium arsenate |
sodium arsenate results in decreased expression of PTEN mRNA | decreases expression | 14713550
|
C009277 |
sodium arsenate |
sodium arsenate results in decreased expression of PTEN protein | decreases expression | 14713550
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of PTEN mRNA | decreases expression | 20056578
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of PTEN mRNA | decreases expression | 16014739
|
D013629 |
Tamoxifen |
PTEN protein results in increased susceptibility to Tamoxifen | increases response to substance | 19435893
|
D013739 |
Testosterone |
Norepinephrine inhibits the reaction [Testosterone results in decreased expression of PTEN mRNA] | decreases expression|decreases reaction | 16954335
|
D013739 |
Testosterone |
Testosterone results in decreased expression of PTEN mRNA | decreases expression | 16954335
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of PTEN mRNA | decreases expression | 17101203
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PTEN mRNA | affects cotreatment|increases expression | 17942748
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of PTEN mRNA | decreases expression | 18796159
|
D013752 |
Tetracycline |
Tetracycline results in increased expression of PTEN mRNA | increases expression | 16917069
|
D014051 |
Toluene 2,4-Diisocyanate |
PTEN protein inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of IL17A mRNA] | decreases reaction|increases expression | 17982072
|
D014051 |
Toluene 2,4-Diisocyanate |
PTEN protein inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of IL17A protein] | decreases reaction|increases expression | 17982072
|
D014051 |
Toluene 2,4-Diisocyanate |
PTEN protein inhibits the reaction [Toluene 2,4-Diisocyanate results in increased expression of RELA protein] | decreases reaction|increases expression | 17982072
|
D014051 |
Toluene 2,4-Diisocyanate |
Toluene 2,4-Diisocyanate results in decreased expression of and results in decreased activity of PTEN protein | decreases activity|decreases expression | 17982072
|
D014241 |
Trichloroethylene |
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of PTEN mRNA | affects cotreatment|increases expression | 17905399
|
C012589 |
trichostatin A |
[Doxorubicin co-treated with trichostatin A] results in increased expression of PTEN mRNA | affects cotreatment|increases expression | 17330857
|
C012589 |
trichostatin A |
PTEN protein affects the susceptibility to [Doxorubicin co-treated with trichostatin A] | affects cotreatment|affects response to substance | 17330857
|
C012589 |
trichostatin A |
trichostatin A promotes the reaction [[EP300 protein co-treated with EGR1 protein] results in increased expression of PTEN mRNA] | affects cotreatment|increases expression|increases reaction | 17330857
|
C012589 |
trichostatin A |
trichostatin A promotes the reaction [HIST3H3 protein modified form binds to PTEN promoter] | affects binding|increases reaction | 17330857
|
C012589 |
trichostatin A |
trichostatin A promotes the reaction [HIST4H4 protein modified form binds to PTEN promoter] | affects binding|increases reaction | 17330857
|
C012589 |
trichostatin A |
trichostatin A results in increased expression of PTEN mRNA | increases expression | 17330857
|
C012589 |
trichostatin A |
trichostatin A results in increased expression of PTEN protein | increases expression | 17330857
|
C025643 |
vinclozolin |
vinclozolin results in increased expression of PTEN mRNA | increases expression | 15686871
|
C017963 |
vinyl carbamate |
vinyl carbamate results in decreased expression of PTEN mRNA | decreases expression | 17849452
|
D002762 |
Cholecalciferol |
Cholecalciferol results in increased expression of PTEN mRNA | increases expression | 16508948
|
C009687 |
wortmannin |
wortmannin inhibits the reaction [PTEN protein results in increased susceptibility to Doxorubicin] | decreases reaction|increases response to substance | 17935137
|
C009687 |
wortmannin |
wortmannin inhibits the reaction [PTEN protein results in increased susceptibility to Etoposide] | decreases reaction|increases response to substance | 17935137
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
3.93 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.26 | 15322242 14514962 11752688 |
MESH:D000015 |
Abnormalities, Multiple |
marker/mechanism |
|
| 18759867 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
2.96 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.33 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
7.10 | 17670903 15814532 12690470 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
7.10 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
nickel sulfate |
3.76 | 16100012 19131640 12718980 11954676 |
MESH:D000230 |
Adenocarcinoma |
marker/mechanism |
|
| 17909629 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
24.87 | 20464547 20127859 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
24.87 | 11798837 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
24.87 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
24.87 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
24.87 | 14692618 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
24.87 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Genistein |
24.87 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Methylnitrosourea |
24.87 | 15688392 15113128 |
MESH:D000230 |
Adenocarcinoma |
|
vinyl carbamate |
24.87 | 17363558 16247444 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
9.13 | 6695378 |
MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
9.13 | 6695378 |
MESH:D000236 |
Adenoma |
|
resveratrol |
9.13 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
8.70 | 16835633 |
MESH:D018248 |
Adenoma, Liver Cell |
|
vinyl carbamate |
8.70 | 12371669 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.09 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.29 | 17306315 16712894 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
3.97 | 21441931 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.42 | 16183991 16162502 |
MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
3.91 | 15469931 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
6.94 | 16511603 15504547 17963324 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
6.94 | 11748828 |
MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
3.90 | 11369114 14761424 17661222 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
3.70 | 17084956 |
MESH:D015858 |
Anisometropia |
marker/mechanism |
|
| 9286463 |
MESH:D000987 |
Antisocial Personality Disorder |
|
Testosterone |
5.24 | 7506515 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.16 | 19015723 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.49 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
2.88 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
6.04 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
6.04 | 17115116 |
MESH:D001249 |
Asthma |
therapeutic |
|
| 17982072 |
MESH:D001249 |
Asthma |
|
Toluene 2,4-Diisocyanate |
3.29 | 18394133 10934080 16210060 170078 8156442 6091946 7684630 12762349 19187332 11077013 15590890 20032816 10797510 12585506 12684321 16792590 15590891 11742282 3040596 17015710 15855793 11467998 6091945 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
4.38 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
2.90 | 16873680 17967414 |
MESH:D001284 |
Atrophy |
|
fulvestrant |
4.28 | 11514358 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 19211884 11496368 18759867 19265751 |
MESH:D001321 |
Autistic Disorder |
|
Norepinephrine |
3.02 | 8570775 |
MESH:D001321 |
Autistic Disorder |
|
Sirolimus |
3.02 | 21115397 |
MESH:D001327 |
Autoimmune Diseases |
|
Cholecalciferol |
9.12 | 16142846 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
9.12 | 19761891 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
2.51 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.18 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.36 | 15746008 |
MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
4.62 | 16183116 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
16.84 | 14601052 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
16.84 | 14601052 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Etoposide |
16.84 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.01 | 15867366 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.33 | 11985600 |
MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
4.35 | 14991843 |
MESH:D020201 |
Brain Hemorrhage, Traumatic |
|
Progesterone |
4.72 | 17868700 |
MESH:D001930 |
Brain Injuries |
|
Progesterone |
3.67 | 15665606 15845082 15380490 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
3.69 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
7.36 | 17150277 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
7.36 | 16436596 15144691 16651633 16357521 18412241 |
MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 20400965 19685490 18066063 19968660 |
MESH:D001943 |
Breast Neoplasms |
|
alitretinoin |
29.00 | 16344269 |
MESH:D001943 |
Breast Neoplasms |
|
Benzene |
29.00 | 11921183 17162533 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
29.00 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
29.00 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
29.00 | 18382427 19526202 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
29.00 | 18320071 19208741 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
29.00 | 15324884 17129689 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
29.00 | 15668708 17369602 16096432 17983394 18234424 15136595 18695136 16322301 19526202 18382427 16264153 15993339 15939500 16595493 18628466 15692762 16826403 15634643 16935488 11325840 15567936 16115903 15994142 17426702 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
29.00 | 17289903 12948864 17261762 18497071 14630087 19861407 17018787 16675129 |
MESH:D001943 |
Breast Neoplasms |
|
Etoposide |
29.00 | 16322251 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
29.00 | 19217205 16557594 18608205 18357371 16110121 16595493 15136595 |
MESH:D001943 |
Breast Neoplasms |
|
fulvestrant |
29.00 | 18984771 |
MESH:D001943 |
Breast Neoplasms |
|
gemcitabine |
29.00 | 17039268 18382427 |
MESH:D001943 |
Breast Neoplasms |
|
Genistein |
29.00 | 16873071 17200150 16541309 |
MESH:D001943 |
Breast Neoplasms |
|
Methylnitrosourea |
29.00 | 16253758 14633655 11306469 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
29.00 | 18223236 15136595 16115903 18323546 11325840 16244791 18234424 16273361 |
MESH:D001943 |
Breast Neoplasms |
|
Progesterone |
29.00 | 16175315 15562024 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
29.00 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
29.00 | 17534123 17651959 16393696 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
29.00 | 20859285 19244106 20390343 18821012 20544844 19189210 19288272 18629630 17049068 16202921 19487384 11161223 21152245 16273361 19221464 15668708 19410462 20065188 19115204 18997820 19103187 20135344 19200415 19066611 15565566 16818667 17440819 19189212 20005174 19142967 16873071 19155303 17893378 19011961 18984771 18855134 19289846 18351453 18815881 19059307 17261762 19084267 21138602 17242785 18425577 |
MESH:D001943 |
Breast Neoplasms |
|
Testosterone |
29.00 | 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
29.00 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Toluene 2,4-Diisocyanate |
29.00 | 11921183 |
MESH:D001943 |
Breast Neoplasms |
|
Trichloroethylene |
29.00 | 15986119 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Toluene 2,4-Diisocyanate |
4.06 | 12507178 8156442 15590891 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
4.93 | 16962696 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.86 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
10.32 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
10.32 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
6.58 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
6.58 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
3.92 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
28.93 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
28.93 | 15948411 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
28.93 | 17876044 18059187 16234567 16023760 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
28.93 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
28.93 | 16799960 16332177 17088986 17971768 18930000 17045692 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
28.93 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
28.93 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
28.93 | 12508355 19519916 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
28.93 | 16227395 19321006 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Sirolimus |
28.93 | 19335982 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
28.93 | 17306315 15276417 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
28.93 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
vinyl carbamate |
28.93 | 12371669 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.39 | 17123778 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
3.99 | 16675471 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
5.39 | 16685392 12023789 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
vinyl carbamate |
5.39 | 16247446 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.37 | 17234771 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
5.61 | 1485588 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
5.61 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
marker/mechanism |
|
| |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
22.18 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
22.18 | 18337622 6189445 17066447 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
22.18 | 19215824 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
22.18 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
22.18 | 18986760 16757204 16280240 17066447 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
22.18 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Sirolimus |
22.18 | 19435901 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
22.18 | 18572023 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.09 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Norepinephrine |
9.47 | 11179087 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
9.47 | 19794523 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
9.47 | 16120746 18670907 18850075 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.12 | 15505089 17928571 16109756 17974986 15476868 16952015 16364871 16278810 17519947 17007740 17308081 16455267 17329180 17382496 17131338 18627295 16731534 17351982 16651473 15811867 16269455 15792986 16612575 17924179 16242529 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.71 | 17334414 16243910 |
MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
9.75 | 16332659 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
9.75 | 16936243 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
9.75 | 15458977 |
MESH:D002375 |
Catalepsy |
|
Norepinephrine |
4.94 | 8216760 |
MESH:D002386 |
Cataract |
|
Methylnitrosourea |
3.61 | 12484553 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
16.56 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
16.56 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
16.56 | 16003739 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitrosourea |
16.56 | 7505956 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
16.56 | 19524636 20056578 |
MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
5.37 | 17160924 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Testosterone |
3.43 | 20678186 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.65 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
2.42 | 17110522 16919318 17333356 15861022 11677210 16105132 17681005 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.82 | 16354765 15340226 12621046 8697196 15668235 |
MESH:D019970 |
Cocaine-Related Disorders |
|
Cocaine |
5.12 | 19606084 |
MESH:D003092 |
Colitis |
|
resveratrol |
3.55 | 16474422 |
MESH:D003110 |
Colonic Neoplasms |
|
Butyrates |
12.08 | 15936596 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
12.08 | 17616700 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
12.08 | 17725105 17287894 16510598 16340194 15001691 17018589 17172411 18772588 17169374 17016597 |
MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
12.08 | 17182828 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
12.08 | 17148506 11134977 15741050 17191121 19440933 19056647 16640504 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
12.08 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
9.18 | 15273666 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
9.18 | 18981723 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
9.18 | 18802399 18259882 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
9.18 | 16303861 17255274 16282729 16331619 17695437 18448328 16524972 16391804 17454858 18949393 20501625 18288408 18383874 15148649 18509181 17401013 18802399 17094418 17594712 14970324 17016601 15289873 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
9.18 | 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
9.18 | 18852136 18095365 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
9.18 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.55 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.34 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
marker/mechanism |
|
| 9286463 14574156 19265751 19321504 17427195 18759867 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
3.46 | 15643154 |
MESH:D019465 |
Craniofacial Abnormalities |
|
sodium arsenate |
3.46 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.46 | 15322242 20055451 10048152 |
MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
9.47 | 12952375 16002989 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
9.47 | 14966744 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.19 | 16733453 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
3.77 | 19031437 |
MESH:D003872 |
Dermatitis |
|
Benzene |
4.18 | 15902427 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
nickel sulfate |
5.73 | 16823706 11298694 16780908 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Toluene 2,4-Diisocyanate |
5.73 | 18759878 12956900 15491423 |
MESH:D003877 |
Dermatitis, Contact |
|
Toluene 2,4-Diisocyanate |
4.24 | 17010967 |
MESH:D002658 |
Developmental Disabilities |
marker/mechanism |
|
| 18759867 19265751 19321504 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
6.91 | 19496084 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
6.91 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
3.70 | 16647724 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
3.70 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
12.08 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
12.08 | 16286809 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
12.08 | 19279558 |
MESH:D003929 |
Diabetic Neuropathies |
|
Progesterone |
3.91 | 17187935 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
12.37 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
pyrazole |
12.37 | 12499123 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
sodium arsenate |
12.37 | 18186108 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
12.37 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetracycline |
12.37 | 17522070 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Trichloroethylene |
12.37 | 7120509 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
11.12 | 12231392 19839026 12649298 15033597 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
11.12 | 18602426 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
11.12 | 11462148 |
MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
5.37 | 18357618 |
MESH:D004487 |
Edema |
|
resveratrol |
5.12 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
5.12 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.29 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
15-deoxy-delta(12,14)-prostaglandin J2 |
22.73 | 16844232 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
22.73 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Progesterone |
22.73 | 17692515 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
22.73 | 17872969 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
22.73 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
11.99 | 19294695 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
trichostatin A |
11.99 | 19294695 |
MESH:D004714 |
Endometrial Hyperplasia |
marker/mechanism |
|
| 16402032 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
9.90 | 16402032 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
9.90 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
marker/mechanism |
|
| 16804899 16402032 12888921 |
MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
18.96 | 16804899 15700306 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
18.96 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
18.96 | 19148513 18566989 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
18.96 | 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
18.96 | 17893378 20544844 16202921 19155303 |
MESH:D004715 |
Endometriosis |
|
Progesterone |
7.19 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
7.19 | 10568697 9294722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.54 | 18037988 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.26 | 17923197 |
MESH:D004802 |
Eosinophilia |
|
Toluene 2,4-Diisocyanate |
4.07 | 8156442 |
MESH:D004827 |
Epilepsy |
|
Norepinephrine |
3.96 | 821787 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
11.70 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
11.70 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
11.70 | 15464296 16481741 15173087 16785472 17638652 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
11.70 | 16481741 15173087 16785472 16337965 17638652 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
11.70 | 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.55 | 11564622 |
MESH:D005128 |
Eye Diseases |
|
Toluene 2,4-Diisocyanate |
5.14 | 18447907 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
10.12 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
10.12 | 14986274 19224547 |
MESH:D005234 |
Fatty Liver |
|
Tetracycline |
10.12 | 19224547 16917069 |
MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
6.91 | 16513791 16611131 16002989 16534752 15751030 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
6.91 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
2.87 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
3.93 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
9.45 | 19069698 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
9.45 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Methylnitrosourea |
4.63 | 11555667 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
6.83 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
6.83 | 20067830 |
MESH:D005391 |
Firesetting Behavior |
|
Testosterone |
5.24 | 7506515 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
4.33 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
4.69 | 16417039 |
MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
10.82 | 16452187 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
10.82 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
22.42 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
22.42 | 16436596 |
MESH:D005909 |
Glioblastoma |
|
Genistein |
22.42 | 16598420 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
22.42 | 19804834 |
MESH:D005909 |
Glioblastoma |
|
Testosterone |
22.42 | 17162496 |
MESH:D005909 |
Glioblastoma |
|
trichostatin A |
22.42 | 18801729 |
MESH:D005910 |
Glioma |
marker/mechanism |
|
| |
MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
11.89 | 18412241 16651633 16357521 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
11.89 | 16145905 |
MESH:D005910 |
Glioma |
|
Methylnitrosourea |
11.89 | 9825942 |
MESH:D005910 |
Glioma |
|
Quercetin |
11.89 | 17643826 |
MESH:D018149 |
Glucose Intolerance |
|
sodium arsenate |
4.52 | 19446573 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
3.98 | 10696789 |
MESH:D006223 |
Hamartoma Syndrome, Multiple |
marker/mechanism |
|
| 11496368 9286463 10353779 10400993 11685670 11748304 14574156 15805158 19321504 17427195 19968660 |
MESH:D006258 |
Head and Neck Neoplasms |
marker/mechanism |
|
| |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
19.72 | 15464296 15102660 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
19.72 | 19215824 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
19.72 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
19.72 | 15162350 15102660 18337622 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Sirolimus |
19.72 | 19435901 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
3.79 | 19898482 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
3.92 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
5.28 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.28 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.05 | 14766674 16144979 16707910 12587719 16879835 16495754 18674790 17888722 18006777 16244371 17875725 16244372 16330681 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
2.95 | 17481944 |
MESH:D006391 |
Hemangioma |
marker/mechanism |
|
| 9286463 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
3.37 | 15692506 |
MESH:D006402 |
Hematologic Diseases |
|
Benzene |
4.10 | 16183116 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
2.80 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
2.32 | 16120746 15340226 12621046 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.42 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
Etoposide |
8.11 | 10809021 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
8.11 | 16876885 |
MESH:D006628 |
Hirsutism |
|
Testosterone |
5.04 | 17019078 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
13.38 | 16200630 16170182 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
13.38 | 15147373 17606976 18501091 |
MESH:D006689 |
Hodgkin Disease |
|
Etoposide |
13.38 | 17606976 15147373 18180244 16200630 16135485 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
13.38 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.14 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.43 | 16354765 16959395 8697196 15340226 18606429 |
MESH:D017588 |
Hyperandrogenism |
|
Testosterone |
4.70 | 17019078 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.47 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
3.51 | 11834736 18262572 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.48 | 16873680 |
MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
3.85 | 14722030 12960047 |
MESH:D006967 |
Hypersensitivity |
|
Toluene 2,4-Diisocyanate |
4.08 | 11019492 10880147 |
MESH:D006973 |
Hypertension |
|
Benzene |
7.14 | 17940673 |
MESH:D006973 |
Hypertension |
|
Quercetin |
7.14 | 18356687 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
7.14 | 18850075 18670907 |
MESH:D006984 |
Hypertrophy |
marker/mechanism |
|
| 19211884 |
MESH:D006984 |
Hypertrophy |
|
Sirolimus |
4.69 | 19211884 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.78 | 17488730 |
MESH:D007006 |
Hypogonadism |
|
Testosterone |
4.14 | 12002444 |
MESH:D007018 |
Hypopituitarism |
|
Testosterone |
5.59 | 17426086 |
MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
9.29 | 16002989 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
9.29 | 16945680 16569931 |
MESH:D007022 |
Hypotension |
|
Norepinephrine |
4.44 | 6740701 |
MESH:D007174 |
Impulse Control Disorders |
|
Testosterone |
5.24 | 7506515 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
Progesterone |
9.54 | 15869954 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
9.54 | 17600658 |
MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
3.78 | 15036965 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
2.91 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
20.93 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
20.93 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
fulvestrant |
20.93 | 11514358 |
MESH:D007248 |
Infertility, Male |
|
Methylnitrosourea |
20.93 | 7193160 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
20.93 | 12646999 15346721 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
20.93 | 16467254 |
MESH:D007249 |
Inflammation |
|
Progesterone |
9.13 | 15869954 |
MESH:D007249 |
Inflammation |
|
resveratrol |
9.13 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
9.13 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
9.13 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
9.16 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
9.16 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
6.06 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
6.06 | 16627594 16393666 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
2.80 | 16580747 |
MESH:C537702 |
Juvenile polyposis syndrome |
marker/mechanism |
|
| |
MESH:D007627 |
Keloid |
|
Quercetin |
4.37 | 17086741 |
MESH:D017492 |
Keratosis, Seborrheic |
|
alitretinoin |
5.04 | 16144296 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
4.53 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
15.10 | 19839026 18289764 15190930 12649298 12231392 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
15.10 | 15369732 15699352 16775033 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
15.10 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
15.10 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
15.10 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
8.33 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
8.33 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
18.15 | 14681315 16762066 15003126 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
18.15 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
18.15 | 17379185 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
18.15 | 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
18.15 | 18625569 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
4.18 | 11231351 |
MESH:D007805 |
Language Development Disorders |
marker/mechanism |
|
| 9286463 |
MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
3.48 | 17184923 |
MESH:D044542 |
LEOPARD Syndrome |
marker/mechanism |
|
| 11685670 |
MESH:D007938 |
Leukemia |
marker/mechanism |
|
| 12970779 |
MESH:D007938 |
Leukemia |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
16.17 | 12970779 |
MESH:D007938 |
Leukemia |
|
Benzene |
16.17 | 14694614 18335105 15935818 17119257 |
MESH:D007938 |
Leukemia |
|
decitabine |
16.17 | 19235587 18980019 |
MESH:D007938 |
Leukemia |
|
Genistein |
16.17 | 18980019 17468513 |
MESH:D007938 |
Leukemia |
|
Quercetin |
16.17 | 17468513 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.54 | 16085563 |
MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
8.00 | 17506065 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
8.00 | 17236224 19117987 18454857 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
5.46 | 19478238 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
5.46 | 19010910 18460780 18704418 17679729 19387464 18206229 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
trichostatin A |
5.46 | 18206229 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
4.85 | 18055864 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.17 | 16087638 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.13 | 16417039 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Methylnitrosourea |
3.76 | 15526292 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
2.71 | 17567588 15342952 |
MESH:D008067 |
Lipoma |
marker/mechanism |
|
| 9286463 |
MESH:D008068 |
Lipomatosis |
marker/mechanism |
|
| 11748304 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.26 | 17353645 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
11.36 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
11.36 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
11.36 | 17823541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Phosphatidylcholines |
11.36 | 16169303 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
11.36 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Sirolimus |
11.36 | 17050028 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
11.36 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
11.36 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
21.17 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
21.17 | 15890375 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
21.17 | 16603448 18383874 17045692 15113037 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
21.17 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
21.17 | 19073162 20405173 19321006 19812893 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
21.17 | 15276417 16712894 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
21.17 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
21.17 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
14.46 | 12562636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
14.46 | 16842330 17085340 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
14.46 | 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
14.46 | 12151625 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Trichloroethylene |
14.46 | 7955063 |
MESH:D038061 |
Lower Extremity Deformities, Congenital |
|
Methylnitrosourea |
4.88 | 16080182 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
2.75 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
4.20 | 14698565 |
MESH:D008175 |
Lung Neoplasms |
marker/mechanism |
|
| 17909629 |
MESH:D008175 |
Lung Neoplasms |
|
alitretinoin |
23.03 | 16413115 |
MESH:D008175 |
Lung Neoplasms |
|
Benzene |
23.03 | 12562636 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
23.03 | 6695378 17053015 20064080 18816296 18569708 18520028 20869020 20464547 20135361 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
23.03 | 6189445 11798837 17225452 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
23.03 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
23.03 | 16271038 17703301 16019985 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
23.03 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Methylnitrosourea |
23.03 | 18062963 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
23.03 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
23.03 | 15276417 16712894 19931552 17077188 17306315 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
23.03 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
23.03 | 19555203 11884234 |
MESH:D008175 |
Lung Neoplasms |
|
vinyl carbamate |
23.03 | 17361011 12117777 11134547 12765245 15824018 11195469 17163412 14755239 16885199 15172992 17363558 12438228 16247444 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.19 | 15086387 |
MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
4.55 | 15166399 |
MESH:D008223 |
Lymphoma |
|
Benzene |
28.39 | 17119257 17584886 |
MESH:D008223 |
Lymphoma |
|
decitabine |
28.39 | 19470736 |
MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
28.39 | 15700306 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
28.39 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
28.39 | 15790496 |
MESH:D008223 |
Lymphoma |
|
Etoposide |
28.39 | 12556972 12854902 |
MESH:D008223 |
Lymphoma |
|
Methylnitrosourea |
28.39 | 16257854 11418001 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Methylnitrosourea |
8.69 | 14633661 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
8.69 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
11.77 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
11.77 | 14749477 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
11.77 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
9.75 | 15621674 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
9.75 | 15375218 |
OMIM:605309 |
MACROCEPHALY/AUTISM SYNDROME |
marker/mechanism |
|
| 15805158 17286265 17427195 |
MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
4.90 | 16002989 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
13.36 | 12562636 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
13.36 | 15688416 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
13.36 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
30.66 | 11921183 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
30.66 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
30.66 | 11408345 11807958 16891317 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
30.66 | 10767621 18041768 10838139 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
30.66 | 14578162 12929590 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Methylnitrosourea |
30.66 | 11751437 16051031 15113128 17131329 15313902 17020996 14999141 16619500 11807958 16944150 10838139 14633655 16827153 12931682 19196723 10767621 15688392 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Progesterone |
30.66 | 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
30.66 | 8985016 11606380 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
30.66 | 14580682 19196722 19196723 16827153 11731420 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
10.61 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
10.61 | 19453300 |
MESH:D008545 |
Melanoma |
marker/mechanism |
|
| 19282848 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
18.68 | 18332650 17761969 12883367 18505091 12393984 16432458 15577323 12374674 11135225 16248763 18176117 17023156 16809738 |
MESH:D008545 |
Melanoma |
|
decitabine |
18.68 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
18.68 | 16827129 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
18.68 | 12025231 12040289 16342250 |
MESH:D008545 |
Melanoma |
|
resveratrol |
18.68 | 17992120 |
MESH:D008545 |
Melanoma |
|
Sirolimus |
18.68 | 19282848 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
18.68 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
18.68 | 12393984 19393235 |
MESH:D008545 |
Melanoma |
|
trichostatin A |
18.68 | 16505122 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
9.51 | 15990972 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
9.51 | 15990972 |
OMIM:155600 |
MELANOMA, CUTANEOUS MALIGNANT |
marker/mechanism |
|
| |
MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
5.37 | 17943659 |
MESH:C537443 |
Meningioma, familial |
marker/mechanism |
|
| |
MESH:D008607 |
Mental Retardation |
marker/mechanism |
|
| 11496368 14574156 18759867 19265751 17427195 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
5.52 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
5.52 | 17638057 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.84 | 17112576 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
3.96 | 15792986 |
MESH:D019957 |
Motor Skills Disorders |
marker/mechanism |
|
| 9286463 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
11.79 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
11.79 | 16757204 18986760 |
MESH:D009062 |
Mouth Neoplasms |
|
Sirolimus |
11.79 | 19435901 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.19 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
Benzene |
18.00 | 17119195 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
18.00 | 18172295 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
18.00 | 14749477 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
18.00 | 14749477 17049120 16267019 17164350 17935668 16490592 |
MESH:D009101 |
Multiple Myeloma |
|
trichostatin A |
18.00 | 18172295 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.27 | 17962980 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
sodium arsenate |
4.31 | 18186108 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.01 | 19157545 18608210 19010910 16882708 |
MESH:D009203 |
Myocardial Infarction |
|
Cocaine |
14.84 | 18072171 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
14.84 | 15857846 19429709 |
MESH:D009203 |
Myocardial Infarction |
|
Genistein |
14.84 | 17141266 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
14.84 | 19595682 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
14.84 | 17188708 17015251 16525036 17125593 16456233 16317513 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
7.40 | 17125593 17015251 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
7.40 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
marker/mechanism |
|
| 19038262 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
16.53 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
16.53 | 17141266 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Norepinephrine |
16.53 | 15642760 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
16.53 | 19207477 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.16 | 17322642 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
7.98 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
7.98 | 15867366 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
7.98 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.29 | 19410462 |
MESH:D009369 |
Neoplasms |
|
alitretinoin |
30.19 | 16946489 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
30.19 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
30.19 | 16773208 |
MESH:D009369 |
Neoplasms |
|
decitabine |
30.19 | 17925555 19470736 19116145 |
MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
30.19 | 15313581 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
30.19 | 18600527 18239605 16928823 |
MESH:D009369 |
Neoplasms |
|
Methylnitrosourea |
30.19 | 15533788 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
30.19 | 15185748 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
30.19 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Trichloroethylene |
30.19 | 11911487 |
MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
22.32 | 16707424 |
MESH:D009374 |
Neoplasms, Experimental |
|
Methylnitrosourea |
22.32 | 12696579 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
22.32 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
22.32 | 20056578 |
MESH:D009374 |
Neoplasms, Experimental |
|
Toluene 2,4-Diisocyanate |
22.32 | 1670384 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.39 | 19196722 19189210 19200415 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.14 | 17289903 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
8.81 | 15464296 |
MESH:D009395 |
Nephritis, Interstitial |
|
Tetracycline |
8.81 | 9884423 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.18 | 16636307 16899518 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
3.49 | 15640375 16889571 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
24.72 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
24.72 | 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
24.72 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Genistein |
24.72 | 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
24.72 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Benzene |
9.95 | 15643154 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenate |
9.95 | 11749123 10525206 19446573 18186108 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
9.95 | 12854658 |
MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
11.29 | 17160924 16003739 16651423 |
MESH:D009442 |
Neurilemmoma |
|
Methylnitrosourea |
11.29 | 11555667 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
6.00 | 8761367 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
6.00 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
3.32 | 17652729 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
4.10 | 8761367 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
8.85 | 17929310 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
8.85 | 17929310 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.01 | 16436463 |
MESH:D009784 |
Occupational Diseases |
|
Benzene |
7.89 | 15612468 15576619 15727169 17479406 17119257 16737584 15935809 17178637 15913788 |
MESH:D009784 |
Occupational Diseases |
|
Toluene 2,4-Diisocyanate |
7.89 | 18394133 3040596 12585506 6091945 6091946 11077013 8156442 |
MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
5.37 | 17160924 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
4.38 | 15867366 |
MESH:D010024 |
Osteoporosis |
|
Genistein |
2.86 | 19401787 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
13.69 | 16169203 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
13.69 | 19495926 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
13.69 | 17513867 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.63 | 15930896 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.39 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one |
34.87 | 16211241 |
MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
34.87 | 12562636 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
34.87 | 6897625 19769630 15464296 17225452 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
34.87 | 19259094 19331143 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
34.87 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
34.87 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
34.87 | 11161223 |
MESH:D010051 |
Ovarian Neoplasms |
|
Progesterone |
34.87 | 16525653 17393432 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
34.87 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
34.87 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
trichostatin A |
34.87 | 19331143 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
24.82 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
24.82 | 19294695 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Etoposide |
24.82 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
24.82 | 19003803 16929163 16500647 15113037 |
MESH:D010190 |
Pancreatic Neoplasms |
|
gemcitabine |
24.82 | 11504793 18992248 16929163 17440100 18383843 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Methylnitrosourea |
24.82 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
24.82 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
trichostatin A |
24.82 | 19294695 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.13 | 11578682 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
3.51 | 12065085 |
MESH:D010300 |
Parkinson Disease |
|
Sirolimus |
3.49 | 19682553 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.63 | 12520081 |
MESH:D010391 |
Pemphigoid, Bullous |
|
Tetracycline |
4.82 | 11026799 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
3.74 | 15464296 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.54 | 17983394 |
MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
4.56 | 14722030 |
MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
4.08 | 15687265 16977796 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
11.90 | 17638057 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
11.90 | 17638057 |
MESH:D017689 |
Polydactyly |
marker/mechanism |
|
| 17427195 |
MESH:D017499 |
Porokeratosis |
|
alitretinoin |
5.39 | 16144296 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
2.99 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
3.47 | 19056647 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
24.13 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
24.13 | 17184923 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
24.13 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
24.13 | 11399792 11118676 11222880 11896295 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
24.13 | 18220299 18042343 19015723 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
10.48 | 17616702 |
MESH:D055728 |
Primary Myelofibrosis |
|
trichostatin A |
10.48 | 17616702 |
MESH:D017096 |
Prion Diseases |
|
Tetracycline |
4.81 | 10903871 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
4.33 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
14.92 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
14.92 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Testosterone |
14.92 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 19396168 16421604 17173048 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
10.29 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bicalutamide |
10.29 | 19011039 19240160 18487222 17914592 15638997 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
10.29 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Cholecalciferol |
10.29 | 17024972 |
MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
10.29 | 15846301 15046698 17136230 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
10.29 | 16868541 15897917 15749863 16729912 16888761 18437689 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
10.29 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Etoposide |
10.29 | 17172428 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
10.29 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
10.29 | 15378649 15256057 16925846 |
MESH:D011471 |
Prostatic Neoplasms |
|
Methylnitrosourea |
10.29 | 15682402 12376480 |
MESH:D011471 |
Prostatic Neoplasms |
|
methylselenic acid |
10.29 | 16205645 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
10.29 | 17136230 17172428 16729912 16356831 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
10.29 | 17292933 14715546 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
10.29 | 17804756 17675339 17636462 15767336 16731767 17718901 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
10.29 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
10.29 | 15067354 |
MESH:D011471 |
Prostatic Neoplasms |
|
trichostatin A |
10.29 | 19789329 18798265 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
4.33 | 18629315 |
MESH:D016715 |
Proteus Syndrome |
marker/mechanism |
|
| 11748304 17427195 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
2.72 | 16919318 15861022 |
MESH:D011618 |
Psychotic Disorders |
|
Cocaine |
4.38 | 16134406 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.18 | 10548101 |
MESH:D011657 |
Pulmonary Eosinophilia |
|
Toluene 2,4-Diisocyanate |
5.01 | 14606601 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.50 | 18722050 16160472 15538739 18286688 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
8.44 | 15464296 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
8.44 | 17922066 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
4.97 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
marker/mechanism |
|
| 19038262 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
2.95 | 16314181 17520802 15827377 17058453 16317513 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Toluene 2,4-Diisocyanate |
4.02 | 16940033 7692837 20219652 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.26 | 18990726 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Toluene 2,4-Diisocyanate |
4.51 | 18447907 |
MESH:D012162 |
Retinal Degeneration |
|
Methylnitrosourea |
3.95 | 18172121 18155124 |
MESH:D012175 |
Retinoblastoma |
|
Methylnitrosourea |
4.88 | 11555667 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
3.85 | 19155313 |
MESH:D012220 |
Rhinitis |
|
Toluene 2,4-Diisocyanate |
4.06 | 19050374 |
MESH:D012221 |
Rhinitis, Allergic, Perennial |
|
Toluene 2,4-Diisocyanate |
4.67 | 12617775 15015336 |
MESH:D006255 |
Rhinitis, Allergic, Seasonal |
|
Toluene 2,4-Diisocyanate |
4.90 | 19075512 |
MESH:D012468 |
Salivary Gland Neoplasms |
|
Progesterone |
2.61 | 18045962 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.47 | 17203757 16767912 17710206 15625365 15675481 18313854 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
14.09 | 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
14.09 | 16326096 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Etoposide |
14.09 | 14601052 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.19 | 17846226 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
4.93 | 16862918 |
MESH:D012640 |
Seizures |
|
Cocaine |
3.65 | 10454489 |
MESH:D012735 |
Sexual Dysfunction, Physiological |
|
Testosterone |
5.59 | 16631401 |
MESH:D012871 |
Skin Diseases |
marker/mechanism |
|
| 19321504 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
22.30 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
22.30 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
22.30 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
22.30 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
22.30 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
22.30 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
22.30 | 16192470 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
4.73 | 15464296 |
MESH:D012912 |
Sneezing |
|
Toluene 2,4-Diisocyanate |
4.90 | 19075512 19050374 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
3.98 | 17203757 15625365 16767912 |
MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
16.60 | 16002989 16709447 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
16.60 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
16.60 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Progesterone |
8.88 | 15862959 16503802 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
8.88 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.32 | 12854658 |
OMIM:275355 |
SQUAMOUS CELL CARCINOMA, HEAD AND NECK |
marker/mechanism |
|
| |
MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
9.03 | 12562636 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
9.03 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
9.03 | 17522103 15958060 18396642 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
9.03 | 19037991 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
9.03 | 17522103 17498489 18396642 18567086 16951190 15786421 19084572 16424979 17172411 19015929 |
MESH:D013274 |
Stomach Neoplasms |
|
Methylnitrosourea |
9.03 | 18593901 15930296 16257854 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
9.03 | 18396642 18506536 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
3.95 | 16321402 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.39 | 16045194 16684133 |
MESH:D013610 |
Tachycardia |
|
Norepinephrine |
4.86 | 3261545 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
4.21 | 16930453 |
MESH:D013733 |
Testicular Diseases |
|
pyrazole |
4.22 | 6499806 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
4.07 | 15464296 17225452 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.06 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.64 | 15669648 |
MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
16.88 | 10850423 |
MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
16.88 | 15790496 |
MESH:D013953 |
Thymus Neoplasms |
|
Methylnitrosourea |
16.88 | 11418001 |
OMIM:188470 |
THYROID CARCINOMA, FOLLICULAR |
marker/mechanism |
|
| |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.29 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Butyrates |
13.40 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
13.40 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
13.40 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
Methylnitrosourea |
13.40 | 7505956 3078959 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.07 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
8.24 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
8.24 | 16227395 |
MESH:D014402 |
Tuberous Sclerosis |
|
Sirolimus |
4.99 | 18495876 21115397 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
23.64 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
23.64 | 15464296 12973940 17225452 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
23.64 | 17616700 19087683 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
23.64 | 17306315 16452187 16712894 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
23.64 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
23.64 | 16720314 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
23.64 | 11723127 17306315 16452187 16712894 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
23.64 | 16712894 17572228 8653321 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
24.10 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
24.10 | 16175088 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
24.10 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
24.10 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
24.10 | 11813266 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
11.78 | 14652134 |
MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
11.78 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
18.26 | 12562636 |
MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
18.26 | 15809267 16690809 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
18.26 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
18.26 | 17044934 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
4.30 | 17785578 |
MESH:D014605 |
Uveitis |
|
Sirolimus |
5.02 | 1336536 |
OMIM:276950 |
VACTERL ASSOCIATION WITH HYDROCEPHALUS |
marker/mechanism |
|
| 11748304 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
9.13 | 15577323 |
MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
9.13 | 16002989 16513791 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
3.82 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
3.98 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.00 | 14671159 15869587 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
8.40 | 17678736 16364871 17334414 17638931 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
8.40 | 17488730 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
4.11 | 11897121 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.63 | 15886252 |